12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

S-555739: Phase IIb data

Top-line data from a Japanese Phase IIb trial showed that once-daily oral S-555739 in combination with an antihistamine met the co-primary endpoints of improving 3 undisclosed nasal...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >